Cosmo Appoints Federico Sommariva as Chief Legal Counsel

Rhea-AI Summary

Cosmo Pharmaceuticals (SIX: COPN, FSE: C43) has announced the appointment of Federico Sommariva as Chief Legal Counsel, reporting directly to the CEO and joining the management team. Sommariva brings extensive legal and management experience from the Lifesciences industry, most recently serving as Director and Global Legal Business Partner Oncology at Gilead Sciences in Milan since 2013. He also held the position of interim Head of Legal and Compliance for Gilead Sciences Romania for 1.5 years.

Sommariva, a University of Milan law graduate, began his career as Legal Counsel Secondee at H&M in Rome. CEO Giovanni Di Napoli expressed confidence that Sommariva's expertise in corporate law and industry knowledge will support the company's long-term growth and help navigate the evolving regulatory landscape.

Positive

• Strengthened legal leadership with experienced industry professional
• Addition of executive with global pharmaceutical industry expertise
• Enhanced regulatory compliance capabilities through new appointment

Negative

• None.

Dublin, Ireland--(Newsfile Corp. - April 1, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced the appointment of Federico Sommariva ad Chief Legal Counsel. Federico reports to the CEO and is member of the management team.

Federico Sommariva has many years of legal and management experience in the Lifesciences industry. Since June 2013, he has worked for Gilead Sciences based in Milan (Italy), with increasing responsibilities. Most recently, he acted as Director and Global Legal Business Partner Oncology. He also served for 1.5 years as interim Head of Legal and Compliance for Gilead Sciences Romania. Federico studied law at the University of Milan and started his professional career as Legal Counsel Secondee at H&M in Rome (Italy).

Giovanni Di Napoli, CEO of Cosmo, commented: “We are delighted to welcome Federico as our new Chief Legal Counsel. With his expertise in corporate law and industry knowledge, he will play a crucial role in guiding our Company through an evolving regulatory landscape and supporting our long-term growth. Federico’s proven track record and commitment make him an invaluable addition to our leadership team.”

Federico Sommariva, Chief Legal Counsel, added: “I am honored to join Cosmo as Chief Legal Counsel and look forward to contributing to its continued success. Cosmo has built a strong reputation for innovation and excellence, and I look forward to working with the management team to navigate the legal and regulatory landscape, thus supporting the Company’s strategic ambitions and objectives.”

About Cosmo

Cosmo Pharmaceuticals N.V. is committed to revolutionizing healthcare and transforming people’s lives by researching and developing innovative products that tackle unfulfilled healthcare demands. As a pharmaceutical company, Cosmo is active in the areas of Healthtech/AI, dermatology, gastroenterology and contract manufacturing & development. For the commercialization and distribution of its products, Cosmo collaborates with leading partners worldwide, including Medtronic and Sun Pharma. Founded in 1997, Cosmo is headquartered in Dublin (Ireland) and has offices also in San Diego (USA), and Lainate/Rome/Catania (Italy). The Company has approximately 330 employees at the end of 2024, all dedicated to making a significant impact in the field of healthcare. For more information, please visit www.cosmopharma.com.

Upcoming Events

Life Sciences Conference, Amsterdam Ordinary Annual General Meeting of Shareholders Investor Day, Zurich	April 2-3, 2025 May 30, 2025 July 1, 2025
2025 Half-Year Results and Report	July 23, 2025

 

For further information, please contact:

investor.relations@cosmopharma.com

Attachments

250401_Cosmo Pharma_Media Release_Chief Legal Counsel_EN_final

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/246892

FAQ

What is Federico Sommariva's background before joining Cosmo Pharmaceuticals (CMOPF)?

He worked at Gilead Sciences Milan since 2013 as Director and Global Legal Business Partner Oncology, served as interim Head of Legal and Compliance for Gilead Romania, and started his career at H&M Rome.

What role will Federico Sommariva have at Cosmo Pharmaceuticals (CMOPF)?

He will serve as Chief Legal Counsel, reporting to the CEO and joining the management team to guide the company through regulatory landscape and support growth.

When does Federico Sommariva start as Chief Legal Counsel at Cosmo Pharmaceuticals (CMOPF)?

The appointment was announced on April 1, 2025.

What are Federico Sommariva's responsibilities at Cosmo Pharmaceuticals (CMOPF)?

He will navigate legal and regulatory landscape, support strategic ambitions, and provide legal guidance as Chief Legal Counsel and management team member.